Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study (September, 10.1007/s12020-020-02501-3, 2020) - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Endocrine Année : 2020

Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study (September, 10.1007/s12020-020-02501-3, 2020)

(1) , (2) , (3) , (4, 5) , (6) , (7) , (8) , (9, 10) , (11) , (12) , (13) , (14, 15, 16) , (17, 18)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Philippe Caron
  • Fonction : Auteur
Yves Brault
  • Fonction : Auteur

Dates et versions

hal-03555792 , version 1 (03-02-2022)

Identifiants

Citer

Emmanuelle Kuhn, Philippe Caron, Brigitte Delemer, Isabelle Raingeard, Herve Lefebvre, et al.. Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study (September, 10.1007/s12020-020-02501-3, 2020). Endocrine, 2020, 71 (1), pp.265. ⟨10.1007/s12020-020-02532-w⟩. ⟨hal-03555792⟩
36 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More